Xueyong Zhu

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 30

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Nature communications

Science (New York, N.Y.)

Science translational medicine

The Scripps Research Institute

University of Science and Technology of China (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The Scripps Research Institute Sep 12 1999

United States

Staff Scientist :: Integrated Structural and Computational Biology

Education History

University of Science and Technology of China Feb 01 1997 - Aug 01 1999

China

PHD :: School of Life Science

Publications

Seiya Kitamura, Ting-Hui Lin, Chang-Chun David Lee, Akihiro Takamura, Rameshwar U Kadam, Ding Zhang, Xueyong Zhu, Lucas Dada, Emiko Nagai, Wenli Yu, Yao Yao, K Barry Sharpless, Ian A Wilson, Dennis W Wolan
Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry. Proceedings of the National Academy of Sciences of the United States of America 121 (22) (2024)
Seiya Kitamura, Ting-Hui Lin, Chang-Chun David Lee, Akihiro Takamura, Rameshwar U Kadam, Ding Zhang, Xueyong Zhu, Lucas Dada, Emiko Nagai, Wenli Yu, Yao Yao, K Barry Sharpless, Ian A Wilson, Dennis W Wolan
Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry. Proceedings of the National Academy of Sciences of the United States of America 121 (22) (2024)
Seiya Kitamura, Ting-Hui Lin, Chang-Chun David Lee, Akihiro Takamura, Rameshwar U Kadam, Ding Zhang, Xueyong Zhu, Lucas Dada, Emiko Nagai, Wenli Yu, Yao Yao, K Barry Sharpless, Ian A Wilson, Dennis W Wolan
Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry. Proceedings of the National Academy of Sciences of the United States of America 121 (22) (2024)
Seiya Kitamura, Ting-Hui Lin, Chang-Chun David Lee, Akihiro Takamura, Rameshwar U Kadam, Ding Zhang, Xueyong Zhu, Lucas Dada, Emiko Nagai, Wenli Yu, Yao Yao, K Barry Sharpless, Ian A Wilson, Dennis W Wolan
Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry. Proceedings of the National Academy of Sciences of the United States of America 121 (22) (2024)
Seiya Kitamura, Ting-Hui Lin, Chang-Chun David Lee, Akihiro Takamura, Rameshwar U Kadam, Ding Zhang, Xueyong Zhu, Lucas Dada, Emiko Nagai, Wenli Yu, Yao Yao, K Barry Sharpless, Ian A Wilson, Dennis W Wolan
Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry. Proceedings of the National Academy of Sciences of the United States of America 121 (22) (2024)
Laetitia E Misson, Hejun Liu, Gabriel Ozorowski, Quoc Tran, Jordan L Woehl, Irene Khalek, Jessica M Smith, Shawn Barman, Fangzhu Zhao, Celina Keating, Oliver Limbo, Megan Verma, Jingjia Liu, Robyn L Stanfield, Xueyong Zhu, Hannah L Turner, Devin Sok, Po-Ssu Huang, Dennis R Burton, Andrew B Ward, Ian A Wilson, Joseph G Jardine
Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulins. Proceedings of the National Academy of Sciences of the United States of America 120 (24) (2023)
Yupeng Feng, Meng Yuan, John M Powers, Mengyun Hu, Jennifer E Munt, Prabhu S Arunachalam, Sarah R Leist, Lorenza Bellusci, Junghyun Kim, Kaitlin R Sprouse, Lily E Adams, Sumana Sundaramurthy, Xueyong Zhu, Lisa M Shirreff, Michael L Mallory, Trevor D Scobey, Alberto C Moreno, Derek T O'Hagan, Harry Kleanthous, François J Villinger, David J Veesler, Neil P King, Mehul S Suthar, Surender Khurana, Ralph S Baric, Ian A Wilson, Bali Pulendran
Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine. Science translational medicine 15 (695) (2023)
Meng Yuan, Linghang Peng, Deli Huang, Amanda Gavin, Fangkun Luan, Jenny Tran, Ziqi Feng, Xueyong Zhu, Jeanne Matteson, Ian A Wilson, David Nemazee
Structural and mechanistic insights into disease-associated endolysosomal exonucleases PLD3 and PLD4. bioRxiv : the preprint server for biology (2023)
Yupeng Feng, Meng Yuan, John M Powers, Mengyun Hu, Jennifer E Munt, Prabhu S Arunachalam, Sarah R Leist, Lorenza Bellusci, Junghyun Kim, Kaitlin R Sprouse, Lily E Adams, Sumana Sundaramurthy, Xueyong Zhu, Lisa M Shirreff, Michael L Mallory, Trevor D Scobey, Alberto C Moreno, Derek T O'Hagan, Harry Kleanthous, François J Villinger, David J Veesler, Neil P King, Mehul S Suthar, Surender Khurana, Ralph S Baric, Ian A Wilson, Bali Pulendran
Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine. Science translational medicine 15 (695) (2023)
Fangzhu Zhao, Meng Yuan, Celina Keating, Namir Shaabani, Oliver Limbo, Collin Joyce, Jordan L Woehl, Shawn Barman, Alison Burns, Quoc Tran, Xueyong Zhu, Michael J Ricciardi, Linghang Peng, Jessica Smith, Deli Huang, Bryan Briney, Devin Sok, David Nemazee, John R Teijaro, Ian A Wilson, Dennis R Burton, Joseph G Jardine
Broadening a SARS-CoV-1-neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution. Science signaling 16 (798) (2023)
Eduard Puente-Massaguer, Kirill A Vasilyev, Annika Beyer, Madhumathi Loganathan, Benjamin Francis, Michael J Scherm, Guha Asthagiri Arunkumar, Irene González Domínguez, Xueyong Zhu, Ian A Wilson, Lynda Coughlan, Weina Sun, Peter Palese, Florian Krammer
Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice. Science advances 9 (37) (2023)
Wan-Ting He, Meng Yuan, Sean Callaghan, Rami Musharrafieh, Sophie Ge Song, Murillo Silva, Nathan Beutler, Wen-Hsin Lee, Peter Yong, Jonathan L Torre, Mariane B Melo, Panpan Zhou, Fangzhu Zhao, Xueyong Zhu, Linghang Peng, Deli Huang, Fabio Anzanello, James Ricketts, Mara Parren, Elijah Garcia, Melissa Ferguson, William Rinaldi, Stephen A Rawlings, David Nemazee, Davey M Smith, Bryan Briney, Yana Safonova, Thomas F Rogers, Jennifer M Dan, Zeli Zhang, Daniela Weiskopf, Alessandro Sette, Shane Crotty, Darrell J Irvine, Andrew B Ward, Ian A Wilson, Dennis R Burton, Raiees Andrabi
Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques. Science translational medicine 14 (657) (2022)
Daniel Stadlbauer, Meagan McMahon, Hannah L Turner, Xueyong Zhu, Hongquan Wan, Juan Manuel Carreño, George O'Dell, Shirin Strohmeier, Zain Khalil, Marta Luksza, Harm van Bakel, Viviana Simon, Ali H Ellebedy, Ian A Wilson, Andrew B Ward, Florian Krammer
Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site. Nature communications 13 (1) (2022)
Daniel Stadlbauer, Meagan McMahon, Hannah L Turner, Xueyong Zhu, Hongquan Wan, Juan Manuel Carreño, George O'Dell, Shirin Strohmeier, Zain Khalil, Marta Luksza, Harm van Bakel, Viviana Simon, Ali H Ellebedy, Ian A Wilson, Andrew B Ward, Florian Krammer
Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site. Nature communications 13 (1) (2022)
Panpan Zhou, Meng Yuan, Sophie Ge Song, Nathan Beutler, Namir Shaabani, Deli Huang, Wan-Ting He, Xueyong Zhu, Sean Callaghan, Peter Yong, Fabio Anzanello, Linghang Peng, James Ricketts, Mara Parren, Elijah Garcia, Stephen A Rawlings, Davey M Smith, David Nemazee, John R Teijaro, Thomas F Rogers, Ian A Wilson, Dennis R Burton, Raiees Andrabi
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection. Science translational medicine 14 (637) (2022)
Daniel Stadlbauer, Meagan McMahon, Hannah L Turner, Xueyong Zhu, Hongquan Wan, Juan Manuel Carreño, George O'Dell, Shirin Strohmeier, Zain Khalil, Marta Luksza, Harm van Bakel, Viviana Simon, Ali H Ellebedy, Ian A Wilson, Andrew B Ward, Florian Krammer
Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site. Nature communications 13 (1) (2022)
Xueyong Zhu, Julianna Han, Weina Sun, Eduard Puente-Massaguer, Wenli Yu, Peter Palese, Florian Krammer, Andrew B Ward, Ian A Wilson
Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface. Proceedings of the National Academy of Sciences of the United States of America 119 (21) (2022)
Daniel Stadlbauer, Meagan McMahon, Hannah L Turner, Xueyong Zhu, Hongquan Wan, Juan Manuel Carreño, George O'Dell, Shirin Strohmeier, Zain Khalil, Marta Luksza, Harm van Bakel, Viviana Simon, Ali H Ellebedy, Ian A Wilson, Andrew B Ward, Florian Krammer
Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site. Nature communications 13 (1) (2022)
Daniel Stadlbauer, Meagan McMahon, Hannah L Turner, Xueyong Zhu, Hongquan Wan, Juan Manuel Carreño, George O'Dell, Shirin Strohmeier, Zain Khalil, Marta Luksza, Harm van Bakel, Viviana Simon, Ali H Ellebedy, Ian A Wilson, Andrew B Ward, Florian Krammer
Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site. Nature communications 13 (1) (2022)
Meng Yuan, Xueyong Zhu, Wan-Ting He, Panpan Zhou, Chengzi I Kaku, Tazio Capozzola, Connie Y Zhu, Xinye Yu, Hejun Liu, Wenli Yu, Yuanzi Hua, Henry Tien, Linghang Peng, Ge Song, Christopher A Cottrell, William R Schief, David Nemazee, Laura M Walker, Raiees Andrabi, Dennis R Burton, Ian A Wilson
A broad and potent neutralization epitope in SARS-related coronaviruses. Proceedings of the National Academy of Sciences of the United States of America 119 (29) (2022)
Meng Yuan, Deli Huang, Chang-Chun David Lee, Nicholas C Wu, Abigail M Jackson, Xueyong Zhu, Hejun Liu, Linghang Peng, Marit J VAN Gils, Rogier W Sanders, Dennis R Burton, S Momsen Reincke, Harald Prüss, Jakob Kreye, David Nemazee, Andrew B Ward, Ian A Wilson
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants. Science (New York, N.Y.) 373 (6556) (2021)
Paul-Albert Koenig, Hrishikesh Das, Hejun Liu, Beate M Kümmerer, Florian N Gohr, Lea-Marie Jenster, Lisa D J Schiffelers, Yonas M Tesfamariam, Miki Uchima, Jennifer Deborah Wuerth, Karl Gatterdam, Natalia Ruetalo, Maria H Christensen, Caroline I Fandrey, Sabine Normann, Jan M P Tödtmann, Steffen Pritzl, Leo Hanke, Jannik Boos, Meng Yuan, Xueyong Zhu, Jonathan L Schmid-Burgk, Hiroki Kato, Michael Schindler, Ian A Wilson, Matthias Geyer, Kerstin U Ludwig, B Martin Hällberg, Nicholas C Wu, Florian Ingo Schmidt
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape. Science (New York, N.Y.) 371 (6530) (2021)
Timothy J C Tan, Meng Yuan, Kaylee Kuzelka, Gilberto C Padron, Jacob R Beal, Xin Chen, Yiquan Wang, Joel Rivera-Cardona, Xueyong Zhu, Beth M Stadtmueller, Christopher B Brooke, Ian A Wilson, Nicholas C Wu
Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain. Nature communications 12 (1) (2021)
Min Qiang, Peixiang Ma, Yu Li, Hejun Liu, Adam Harding, Chenyu Min, Fulian Wang, Lili Liu, Meng Yuan, Qun Ji, Pingdong Tao, Xiaojie Shi, Zhean Li, Teng Li, Xian Wang, Yu Zhang, Nicholas C Wu, Chang-Chun David Lee, Xueyong Zhu, Javier Gilbert Jaramillo, Chuyue Zhang, Abhishek Saxena, Xingxu Huang, Hou Wang, William S James, Raymond A Dwek, Ian A Wilson, Guang Yang, Richard A Lerner
Neutralizing Antibodies to SARS-CoV-2 Selected from a Human Antibody Library Constructed Decades Ago. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2021)
Meng Yuan, Hejun Liu, Nicholas C Wu, Chang-Chun David Lee, Xueyong Zhu, Fangzhu Zhao, Deli Huang, Wenli Yu, Yuanzi Hua, Henry Tien, Thomas F Rogers, Elise Landais, Devin Sok, Joseph G Jardine, Dennis R Burton, Ian A Wilson
Structural basis of a shared antibody response to SARS-CoV-2. Science (New York, N.Y.) 369 (6507) (2020)
Meng Yuan, Nicholas C Wu, Xueyong Zhu, Chang-Chun David Lee, Ray T Y So, Huibin Lv, Chris Ka Pun Mok, Ian A Wilson
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science (New York, N.Y.) 368 (6491) (2020)
Nicholas C Wu, Meng Yuan, Hejun Liu, Chang-Chun David Lee, Xueyong Zhu, Sandhya Bangaru, Jonathan L Torre, Tom G Caniels, Philip J M Brouwer, Marit J VAN Gils, Rogier W Sanders, Andrew B Ward, Ian A Wilson
An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain. bioRxiv : the preprint server for biology (2020)
Daniel Stadlbauer, Xueyong Zhu, Meagan McMahon, Jackson S Turner, Teddy J Wohlbold, Aaron J Schmitz, Shirin Strohmeier, Wenli Yu, Raffael Nachbagauer, Philip A Mudd, Ian A Wilson, Ali H Ellebedy, Florian Krammer
Broadly protective human antibodies that target the active site of influenza virus neuraminidase. Science (New York, N.Y.) 366 (6464) (2020)
Yao Yao, Rameshwar U Kadam, Chang-Chun David Lee, Jordan L Woehl, Nicholas C Wu, Xueyong Zhu, Seiya Kitamura, Ian A Wilson, Dennis W Wolan
An influenza A hemagglutinin small-molecule fusion inhibitor identified by a new high-throughput fluorescence polarization screen. Proceedings of the National Academy of Sciences of the United States of America 117 (31) (2020)
Nicholas C Wu, Meng Yuan, Sandhya Bangaru, Deli Huang, Xueyong Zhu, Chang-Chun David Lee, Hannah L Turner, Linghang Peng, Linlin Yang, Dennis R Burton, David Nemazee, Andrew B Ward, Ian A Wilson
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody. PLoS pathogens 16 (12) (2020)

Xueyong Zhu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xueyong Zhu